Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
10 NEW July 15, 2019

Improving HIV clinical trials with mobile technology

From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Science Spotlight - July 15, 2019

New Scientific Publications

Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
1 NEW Week of July 14, 2019

Could gold be the key to making gene therapy for HIV and other blood disorders more accessible?

A proof-of-principle study published in Nature Materials shows that gold nanoparticles loaded with CRISPR and other gene-editing tools safely and effectively edited blood stem cells. (Photos, diagram available for media use.)
Releases - May 27, 2019

Special delivery: Gold nanoparticles ship CRISPR cargo

Fred Hutch scientists used their new golden courier to edit genes tied to HIV, genetic blood disorders
Hutch News - May 27, 2019

Increased racial and ethnic minority participation in HIV vaccine trials

From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Science Spotlight - March 18, 2019

Sabes study fuels comprehensive HIV research

From the Duerr lab, Vaccine and Infectious Disease Division, and collaborators
Science Spotlight - February 18, 2019

'Cautiously optimistic about HIV vaccines'

A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey
Hutch News - November 30, 2018

One step closer to the Berlin Patient and an HIV cure

Kiem Lab, Clinical Research Division and Vaccine and Infections Disease Division
Science Spotlight - June 18, 2018

Predicting a moving target’s next move

From the Bloom Lab, Basic Sciences Division
Science Spotlight - June 18, 2018

Gene editing holds promise for shrinking HIV ‘reservoir’

Study mimicking Timothy Ray Brown’s HIV-resistant mutation led to fewer latently infected cells — a key step toward driving the virus into remission without the need for antivirals
Hutch News - April 25, 2018

Curbing HIV transmission by HSV-2 treatment

From the Barnabas and Hughes Laboratory, Vaccine and Infectious Disease Division
Science Spotlight - February 19, 2018

Insights from infants could inform HIV vaccine design

Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV
Hutch News - November 27, 2017
Last Modified, July 11, 2019